Related Experiment Videos

Fifteen years of research of bioactive alkaloids

¹Natural Products Section, National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, Maryland 20817.

Medicinal Research Reviews

|January 1, 1992

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory action.

Journal of medicinal chemistry·2001

Phenserine regulates translation of beta -amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development.

Proceedings of the National Academy of Sciences of the United States of America·2001

The experimental Alzheimer drug phenserine: preclinical pharmacokinetics and pharmacodynamics.

Acta neurologica Scandinavica. Supplementum·2001

Mapping the binding site of colchicinoids on beta -tubulin. 2-Chloroacetyl-2-demethylthiocolchicine covalently reacts predominantly with cysteine 239 and secondarily with cysteine 354.

The Journal of biological chemistry·2000

Anti-AIDS agents part 41: synthesis and anti-HIV activity of 3',4'-di-o-(-)-camphanoyl-(+)-cis-khellactone (DCK) lactam analogues.

Bioorganic & medicinal chemistry letters·2000

Asymmetric solid-phase synthesis of (3'R,4'R)-di-O-cis-acyl 3-carboxyl khellactones.

Organic letters·2000

See all related articles